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S_q The geetic origin of two placental site trophoblastic tumours was etablhed using a Y
chromosome-spcf and locus-speciic miisatelite probe A gestatonal orgin was confirml for both
tumours. In one cae the origin of the tumour was consistent with derivation from a normal female conceptus
while the other was shown to arise from a homozygous hydatidiform mole, an abnormal conceptus
more usually associated with the development of choriocarcinoma.
Placental site trophoblastic tumours (PSTT) are rare gesta-
tional trophoblastic tumours. They resemble the intermediate
trophoblast of the placental bed and are distinguished from
the more common gestational trophoblastic tumour, chorio-
carcinoma, by having few multinucleated syncytial cells,
abundant cytoplasmic human placental lactogen (hPL), low
level of human chorionic gonadotrophin (hCG) production
(Kurman et al., 1984) and relative resistance to standard
trophoblastic disease chemotherapy (Lathrop et al., 1988).
Although choriocarcinoma can follow any type of preg-
nancy approximately half follow pregnancy with complete
hydatidiform mole, an unusual conceptus which has two
paternal sets of chromosomes and is therefore androgenetic
in origin (Kajii & Ohama, 1977). PSTr, however, generally
follow term pregnancies or non-molar abortions (WHO,
1983) although a small number have been described in
pateints with a clinical history of hydatidiform mole (Lath-
rop et al., 1988; Dessau et al., 1990).
Genetic studies have confirmed the origin of choriocar-
cinoma from normal term pregnancy or homozygous or
heterozygous complete hydatidiform moles (Fisher et al.,
1988; Chaganti et al., 1990; Fisher et al., 1992), but have also
shown that the causative pregnancy in trophoblastic tumours
is not always the antecedent pregnancy (Fisher et al., 1992).
Thus a clinical diagnosis of post-term or post-mole PSTT is
not conclusive evidence of the origin of the tumour.
We report here two cases of PSTT in which the genetic
origin has been established using a Y chromosome-specific
probe CY84 (Wolfe et al., 1985) and a panel of locus-specific
minisatellite probes, which identify highly polymorphic
restriction fragment length polymorphisms (RFLPs) of the
DNA (Wong et al., 1987; Armour et al., 1990). One case was
shown to originate in a normal conceptus and the other from
a prgnancy with hydatidiform mole.
Patieds and -t-
S.J. was a 28 years old Caucasian who had four full term
normal deliveries of a male and three females, the last
delivery of a female child being 16 months previously. She
presented with irregular vaginal bleeding and pathological
examination of tissue following dilatation and curettage
showed PSTT (Figure 1). A hysterectomy performed 6 weeks
later confirmed the histological diagnosis of PSTT.
J.D. was a 29 year old Caucasian with an obstetric history
of one full term normal delivery 5 years previously and a
hydatidiform mole 16 months prior to presentation. She
presented with a 6 month history of vaginal bleeding. When
hysterectomy was performed 2 months after presentation
pathological examination showed a PSTT.
Pathological diagnosis of the tumours was carried out
following routine histological examination. Tumours were
characterised immunohistochemically with a monoclonal
antibody to hCG (INN 13-Serotec) and a rabbit polyclonal
antisera to hPL using an avidin biotin peroxidase technique
(Kardana et al., 1988). Fresh tissue was available for DNA
analysis from the primary tumour in both cases. Tumour
tissue was cut into small pieces and then snap frozen in liquid
nitrogen. Seven cryostat sections were cut from each piece
and stained with haematoxylin and eosin. Areas comprising
mainly tumour cells were idntified and corresponding areas
dissected out from the frozen tissue. DNA was ppamred
from this tissue using standard techniques. Ten ml samples of
heparinised blood were used to prepare DNA from the
patient and her partner.
RFLPs of the DNA, defined by the locus-specific mini-
satellite probe MSI (Wong et al., 1987), were examined in
HinfI digested parental and tumour DNA as previously de-
scribed (Wong et al., 1987; Fisher et al., 1989). The probe
was subsequently stripped from the DNA and rehybridisa-
tion carried out successively with probes MS8, MS31, p4g3,
MS43 and MS621 (Wong et al., 1987; Armour et al., 1990).
In the case JD parental and tumour DNA was reprobed with
three additional locus-specific minisatellite probes MS605,
MS622 and MS620 (Armour et al., 1990). The chromosomal
location, heterozygosity and allelic length range of these
probes are shown in Table I.
To examine tumours for Y chromosome-specific sequences,
5 ILg of DNA was digested with EcoRI, hybridised with
CY84, and examined for the presence or absence of the
5.5 kb male-specific band (Wolfe et al., 1985).
Resnis
No Y chromosome-specific sequences were identified in either
of the two tumours. RFLPs identified with the locus-specific
minisatellite probes are shown in Table II.
Si.
Examination of DNA from tumour tissue with probes MSI,
MS31, MS43 and MS621 showed the presence of a paternal
band in the tumour tissue confirming gestational origin. Of
these probes the maternal sample was heterozygous for
RFLPs identified with MS1, MS31, and MS621. All three
probes demonstrated the presence of both maternal aleles in
the DNA prepared from the tumour. However, the relative
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different to those in the maternal tissue itself (Figure 2)
indicating that one allele was there at an increased dosage
due to its presence both in the tumour genome and the DNA
from infiltrating host cells. Results with MS8 and pkg3 were
uniformative due to sharing of alleles by the parents.
J.D.
The probes MSI (Figure 3) and MS31 identified a paternal
contribution in this tumour. However. due to sharing of
parental alleles probes MS8. pAg3. MS43 and MS621 were
uninformative in this respect. Three additional probes.
MS605. MS622 and MS620 used to examine this case all
showed a single paternal band in the tumour indicating that
the tumour was androgenetic and therefore had originated
from a pregnancy with hydatidiform mole. Although MS43A
was uninformative in terms of parental origin the father was
heterozygous while the tumour had only a single band com-
patible with paternal origin (Figure 3). Similarly pAg3. MS31
and MS621 identified hererozygous alleles in the father only
one of which was present in the tumour. The tumour was
thus homozygous for eight unlinked autosomal loci for which
the father was heterozygous. Absence of Y chromosome-
specific sequences in this tumour suggests that it was also
homozygous for the X chromosome.
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Fugwe 1 Appearance of the tumour in hysterectomy specimen
from patient SJ. a, Haematoxylin and eosin. b, Indirect
immunoperoxidase for human placental lactogen (hPL). x 250.
Most cells are positive for hPL with a few cells being strongly
positive.
Fgwe 2 RFLPs detected with MS31 in DNA from the patient,
tumour tissue and her partner in case SJ. A paternal contn-
bution to the tumour c is indicated. The increased intensity of the
maternal allele b relative to allele a in the tumour sample com-
pared to that in the patient DNA indicates the presence of a
maternal contribution b to the tumour genome in addition to
maternal DNA ab derived from host tissue infiltrating the
tumour.
Table I Locus-specific minisatellite probes used to examine DNA from cases of PSTT
Probe MSI MS8 MS31 pAg3 MS43< MS621 MS605 MS622 MS620
Chromosomal lp33-p35 5q35-qter 7p22-pter 7q36-qter 12q24.3-qter 5p 6q l0q 15q
location
Heterozygosity 99.4 85.1 98 97.4 95.9 92 87 83 91
(%)
Allelic length 2.0-22.0 2.4-9.5 3.5-13 0.6-20 3.5-16 - - - -
range (kb)
'The probe MS43 identifies two very closely linked polymorphic loci MS43A and MS43B (Royle et al., 1988). The details
given are for the major polymorphism MS43A. References: Wong et al., 1987; Jeffreys et al., 1988; Royle et al., 1988; Armour
et al., 1990.
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Tabl n Restriction fragment length polymorphisms identified in cases of PSTT
Probe MSJ MS8 MS31 pig3 MS43A B AMS621 MS5605 MS622 115620
Case S.J.
patient ab* a ab ab ab a ab
tumour ad (ab)** a bc (ab) ab ab ab ac (ab)
partner cd ac cd bc ac ab bc
Case J.D.
patient ab ab ab ab ab a abc+ ab ab ab
tumour d a d b b a a c d c
partner cd a cd bc bc a ad cd cd cd
*The letters a, b. c. d are used to differentiate between different band sizes within a case and do not
represent specific polymorphisms. **RFLPs given in brackets represent those of ifitrating host cells.
'Three bands present in the maternal sample suggest the presence of a Hinfl restriction site within the
RFLP giving rise to two bands at one locus.
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Figure 3 RFLPs detected with MSI and MS43 in DNA from
the patient. tumour tissue and her partner in case J.D. The
patient and her partner are heterozygous for both loci although
they have an RFLP b in common at the MS43A locus. The single
band d identified in the tumour with probe MSI is clearly of
paternal origin while the single band b identified at the MS43A
locus is compatible with a paternal origin.
DEiscus
Three types of gestational trophoblastic tumours are now
recognised, invasive mole. a relatively benign tumour follow-
ing pregnancy with hydatidiform mole, choriocarcinoma and
PSTT. PS1T is a relatively rare lesion previously known by a
variety of names such as chorioma. atypical choriocarcinoma
and trophoblastic pseudotumour (Scully & Young. 1981). It
resembles the trophoblast of the placental bed at the site of
implantation and is therefore composed of mainly
intermediate trophoblast in contrast to choriocarcinoma
which exhibits a dimorphic pattern of cytotrophoblast and
syncytiotrophoblast which resembles villous trophoblast.
Absence of extensive haemorrhage and predominant inter-
stitial rather than intravascular infiltration also distinguish
PSTT from choriocarcinoma.
Genetic studies have shown that choriocarcinoma mav
derive from a normal conceptus having both maternal and
paternal contributions to the genome (Wake et al.. 1981:
Chaganti et al.. 1990; Fisher et al., 1992) or from a preg-
nancy with complete hydatidiform mole which is andro-
genetic, having only a paternal contribution to the nuclear
genome (Fisher et al., 1988; Fisher et al.. 1992). One study
also demonstrated that the immediately antecedent preg-
nancy is not always the causative pregnancy, one patient with
a post-mole tumour having had an intervening pregnancy
with normal full term delivery of twins (Fisher et al.. 1992).
Thus a clinical diagnosis of post-term or post-mole tumour
may not always be biologically correct.'
Few cases of PSTT have previously been examined geneti-
cally. Two cases have been reported as diploid (Eckstein et
al.. 1985; Lathrop et al., 1988) in contrast to the more
aneuploid karyotypes usually described in choriocarcinomas
(Makino et al., 1965; Wake et al., 1981: Sheppard et al.,
1985: Lawler & Fisher. 1986). We are not aware of any
studies where the origin of PSTT has been examined. Unlike
choriocarcinoma. where approximately half occur following
molar pregnancies, most reported cases of PSTT have fol-
lowed term pregnancies or non-molar abortions (WHO,
1983; Lathrop et al., 1988). The present study was under-
taken to examine the genetic origin of two PSTT using DNA
analysis, and to determine the nature of the causative preg-
nancy in each case. In both cases examination with locus-
specific probes established the presence of a paternally
derived band confirming their gestational origin.
Further interpretation of results in case S.J. was compli-
cated by the presence of a high proportion of DNA from
infiltrating host cells. DNA from intervening host cells will
have RFLPs identical to those of the patient and is suggested
by the presence of both maternal bands in the tumour track
in addition to one or more paternal bands. In case S.J. the
relative difference in intensity of the two maternal bands in
the tumour track compared with the patient sample (Figure 2).
suggests that one allele is present both in the contaminating
host and the tumour DNA. The presence of both a maternal
and paternal contribution to the tumour. in the absence of Y
chromosome-specific sequences would be consistent with an
origin from a normal female conceptus.
In the case J.D.. only a single band was seen with each
minisatellite probe used and in all tests was paternal or
compatible with a paternal origin. No maternal contribution
to the tumour genome was identified. An origin from an
androgenetic complete mole was thus highly likely. Complete
hydatidiform moles may be homozygous deriving from the
doubling of a haploid sperm following fertilisation of an
enucleate egg (Lawler et al.. 1979: Jacobs et al.. 1980) or
heterozygous arising by dispermy (Ohama et al., 1981). The
former are female while the latter may be male or female.
Choriocarcinoma has been shown to follow both types of
hydatidiform mole (Fisher et al., 1988). Homozygosity in the
tumour J.D. for eight independently segregating markers
heterozygous in the father, together with the absence of
Y-specific sequences makes it statistically unlikely that the
tumour followed a heterozygous complete mole (P<0.002)
and it is therefore most likely that the PSTT arose from a
homozygous complete mole.
Attempts were made to establish the origin of a third case
of PSTT in a patient (A.H.) with a history of hydatidiform
mole. However, pathological examination of the tumour
showed large numbers of infiltrating cells and several
preparations of DNA from tumour tissue resulted in DNA
which were mostly of host origin. The use of sections from
formalin-fixed, paraffin-embedded blocks in combination358 R.A. FISHER et al.
with new techniques such as polymerase chain reaction tech-
nology which require very small amounts of DNA (Shibata
et al., 1988) may enable the origin of this case, and other
cases where fresh materal is not available to be resolved.
DNA analysis has made it possible to confirm that two
tumours with the pathology of PSTT were gestational in
origin and to show that PSTI may originate not only in a
normal term pregnancy but also after a complete
hydatidiform mole, the latter being more usually associated
with the gestational trophoblastic tumour, choriocarcinoma.
Thus gestational tumours following hydatidiform mole may
be invasive mole, choriocarcinoma or PSTT.
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